Saturday, October 19, 2024 - 7:00 am - 8:00 am

Industry Sponsored Short Snapper Sessions #1

What Could be Disease Clearance in Ulcerative Colitis? Evolution of Treatment Goals in UC

Session Objectives

• Explore the concepts of disease clearance and disease modification and their clinical implications in IBD.​
• Review and discuss clinical data from different advanced therapies that support the achievement of disease clearance in UC.​

Natasha Bollegala, Hon BSc., MD, MSc., FRCPC

Staff Gastroenterologist, Women’s College Hospital
Assistant Professor, Faculty of Medicine, University of Toronto
Fellow in the Institute of Clinical Evaluative Sciences (ICES)

Dr. Natasha Bollegala is a staff gastroenterologist at Women’s College Hospital, and assistant professor in the department of medicine, University of Toronto (UofT). She is a clinician in quality and innovation and completed an Inflammatory Bowel Disease (IBD) fellowship at Mount Sinai Hospital, Toronto, an MSc in clinical epidemiology and healthcare research at UofT in 2016, the Eliot Phillipson Clinician Scientist Training Program and the Clinician Investigator Program at the University of Toronto.

Dr. Bollegala conducts research with a particular focus on pediatric to adult transition of care and is co-principal investigator for the national transition arm of the Promoting Access to Care in IBD (PACE) quality improvement program of Crohn’s and Colitis Canada (CCC). She co-chairs the Canadian IBD Transition Network (CITE). She has published and presented on the topic of gender in gastroenterology. She is co-chair of the Innovations sub-committee for the Quality Affairs Committee of the Canadian Association of Gastroenterology (CAG). She serves as Treasurer for the Ontario Association of Gastroenterology (OAG).